Department of Animal Biosciences, Animal Science and Nutrition, University of Guelph, Guelph, ON, Canada N1G 1Y2.
Lallemand SAS, F-31702 Blagnac, France.
J Dairy Sci. 2022 Aug;105(8):7125-7139. doi: 10.3168/jds.2021-21768. Epub 2022 Jun 7.
This study was designed to develop a protocol for repeated intramuscular indomethacin injections to replicate leaky-gut-like symptoms in male Holstein calves to model and study the detrimental effects of leaky gut on gut tissue function and inflammatory response. A generalized randomized block design was used to evaluate how repeated indomethacin intramuscular injections affected the development of leaky gut in 18 male Holstein calves. Animals were enrolled at 3 ± 1 d of life, and after 21 d of adaptation, they were randomly assigned to 1 of 3 treatments consisting of intramuscular saline or indomethacin injections every 12 h for 48 h: (1) control (CTL), saline injection, (2) low intramuscular indomethacin (INDO-L) dosed at 1.2 mg/kg of body weight (BW), and (3) high intramuscular indomethacin (INDO-H) dosed at 2.4 mg/kg of BW. During the challenge, milk intake, starter intake, fecal scores, and rectal temperature were measured daily, and BW was measured at the beginning and at the end of the challenge. Plasma samples were used to measure the recovery of markers of intestinal permeability before and after the challenge by dosing lactulose, d-mannitol, and chromium-EDTA. In addition, several cytokines were measured in plasma during the challenge. Calves were dissected at the end of the challenge to obtain tissue and digesta samples from the gastrointestinal tract and liver. No treatment differences were observed for starter and milk intakes, fecal scores, BW, and rectal temperature. The difference in marker concentrations between pre and post challenges was higher for INDO calves compared with CTL calves in the case of lactulose and chromium-EDTA. In addition, chemokine ligand 2 and 4 and IL-6 were higher for INDO-H calves compared with CTL. Both doses of indomethacin resulted in reductions in villus length and surface area in the distal jejunum and ileum and reductions in crypt depth and width in the colon. We showed that repeated indomethacin injections over a 48-h period induced leaky-gut-like symptoms in a region-specific manner, affecting mainly the distal section of the intestine. This outcome was characterized by histomorphological changes in the distal jejunum, ileum, and colon and by increased gut permeability. Interestingly, changes in liver morphology and immune function also occurred, possibly due to the increased translocation of foreign antigens breaching the epithelial cell wall. The leaky gut challenge model described here could be used to improve understanding of the pathogenesis of intestinal disorders in cattle and provide a reliable alternative for testing feed additives with intestinal health benefits.
本研究旨在制定一项方案,通过对雄性荷斯坦小牛进行重复的肌肉内吲哚美辛注射,以复制肠漏样症状,从而对肠漏对肠道组织功能和炎症反应的有害影响进行建模和研究。采用广义随机区组设计来评估重复肌肉内吲哚美辛注射如何影响 18 头雄性荷斯坦小牛的肠漏发展。动物在 3±1 日龄时入组,适应 21 天后,随机分为 3 种处理组,每组 6 头:(1)对照组(CTL),肌肉内注射生理盐水;(2)低剂量肌肉内吲哚美辛(INDO-L),剂量为 1.2mg/kg 体重;(3)高剂量肌肉内吲哚美辛(INDO-H),剂量为 2.4mg/kg 体重。在挑战期间,每天测量牛奶摄入量、开食料摄入量、粪便评分和直肠温度,并在挑战开始和结束时测量体重。在挑战前后,通过给予乳果糖、D-甘露醇和铬-EDTA,测量血浆样本中肠道通透性标志物的恢复情况。此外,在挑战期间还测量了几种细胞因子在血浆中的水平。在挑战结束时对小牛进行解剖,以从胃肠道和肝脏获得组织和消化物样本。在开食料和牛奶摄入量、粪便评分、体重和直肠温度方面,各处理组之间没有差异。与 CTL 小牛相比,INDO 小牛的乳果糖和铬-EDTA 标志物浓度在挑战前后的差异更高。此外,INDO-H 小牛的趋化因子配体 2 和 4 以及 IL-6 水平高于 CTL 小牛。两种剂量的吲哚美辛均导致远端空肠和回肠的绒毛长度和表面积减少,以及结肠隐窝深度和宽度减小。我们表明,在 48 小时的时间内重复肌肉内注射吲哚美辛会以特定于区域的方式诱导肠漏样症状,主要影响肠道的远端部分。这种结果的特征是远端空肠、回肠和结肠的组织形态学变化以及肠道通透性增加。有趣的是,肝脏形态和免疫功能也发生了变化,这可能是由于穿透上皮细胞壁的外来抗原的移位增加所致。这里描述的肠漏挑战模型可用于提高对牛肠道紊乱发病机制的理解,并为具有肠道健康益处的饲料添加剂的测试提供可靠的替代方法。